Left Ventricular Structure, Geometry and Systolic Function among Hypertensive Black Patients with Reduced Kidney Function


Objective: To assess the LV mass, geometry and systolic function in hypertensive patients with reduced kidney function. Methods: According to ASE guidelines, we estimated LV ventricular mass, geometry and systolic function in 155 consecutive hypertensive patients [51% women, mean age 51 ± 12 years, median duration of hypertension 7 years] with reduced kidney function (eGFR < 60 ml/min/1.73 m2 or dipstick proteinuria ≥ 1+). LVH was defined as LVMI >125 g/m2 in men, >110 g/m2 in non obese women or >51 g/m2.7 for obese men or women. Where appropriate, we used Student t, Mann Whitney, one way ANOVA or Chi square tests. A P value of 0.05 or less was considered significant. Results: Seventy four patients in the series (48%) had reduced kidney function (eGFR 30 ± 15 ml/min/1.73 m2). Compared to patients with relatively normal kidney function, non obese and obese patients with reduced kidney function had significantly greater LVM [271 (198 - 348) vs 276 (175 - 284) g/m2, p = 0.008] for non obese; LVM 72 (47 - 88) vs 54 (44 - 73) g/m2.7, p = 0.007 for obese] and lower EF (60 ± 14 vs 68 ± 13%, p < 0.001) was significantly lower. LVH of mainly concentric geometric pattern was present in 68 patients with reduced kidney function (92%). Conclusion: In the present case series, reduced kidney function was associated with increased LVM, concentric geometric pattern and impaired systolic function.

Share and Cite:

Mpembe, B. , Lepira, F. , Mbutiwi, F. , Makulo, J. , Kintoki, E. , Bayauli, M. and M’Buyamba-Kabangu, J. (2015) Left Ventricular Structure, Geometry and Systolic Function among Hypertensive Black Patients with Reduced Kidney Function. World Journal of Cardiovascular Diseases, 5, 287-295. doi: 10.4236/wjcd.2015.510032.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Chahal, N.S., Lim, T.K., Jain, P., Chambers, J.C., Kooner, J.S. and Semior, R. (2010) New Insights into the Relationship of Left Ventricular Geometry and Left Ventricular Mass with Cardiac Function: A Population Study of Hypertensive Subjects. European Heart Journal, 31, 588-594.
[2] Schiffrin, E., Lipman, M.L. and Mann, J.F.E. (2007) Chronic Kidney Disease. Effects on the Cardiovascular System. Circulation, 116, 85-97.
[3] Shahbaz, A.U., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., McGee, J.E. and Xeber, K.T. (2010) Fibrosis in Hypertensive Heart Disease: Molecular Pathways and Cardioprotective Strategies. Journal of Hypertension, 28, S25-S32.
[4] Iwashima, Y., Horio, T., Kamide, K., Tokudome, T., Yoshihara, F., Nakamura, S., et al. (2010) Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy and Risk of Cardiovascular Disease in Hypertension. American Journal of Hypertension, 23, 290-298.
[5] Levin, A. (2003) Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to Dialysis. Seminars in Dialysis, 16, 101-105.
[6] M’Buyamba-Kabangu, J.R., Fagard, R., Staessen, J., Lijnen, P. and Amery, A. (1987) Comparison of Blood Pressure and Prevalence of Hypertension in Rural and Urban Zaire. Bibliotheca Cardiologica, 42, 80-87.
[7] Sumaili, E.K., Nseka, M.N., Lepira, F.B., Krzesinski, J.M., Makulo, J.R., Bukabau, J.B., et al. (2008) Screening for Proteinuria and Chronic Kidney Disease Risk Factors in Kinshasa: A World Kidney Day 2007 Study. Nephron Clinical Practice, 110, c220-c228.
[8] Katchunga, P.B., M’Buyamba-Kayamba, J.R., Masumbuko, B.E., Lemogum, D., Kashongwe, Z.M., Degaute, J.P., et al. (2011) Hypertension in the Adult Congolese Population of Southern Kivu: Results of the VITARAA Study. [French]. La Presse Médicale, 40, e315623.
[9] M’Buyamba-Kabangu, J.R., Biswika, R.T., Thijs, L., Tshimanga, G.M., Ngalula, F.M., Disashi, T., et al. (2009) In-Hospital Mortality among Black Patients Admitted for Hypertension-Related Disorders in Mbuji Mayi, Congo. American Journal of Hypertension, 22, 643-648.
[10] Lepira, F.B., M’Buyamba-Kabangu, J.R., Kayembe, P.K. and Nseka, M.N. (2006) Clinical Correlates of Left Ventricular Hypertrophy in Black Patients with Arterial Hypertension. Cardiovascular Journal of Africa, 17, 7-11.
[11] Bayauli, M.P., Lepira, F.B., Kayembe, P.K. and M’Buyamba-Kabangu, J.R. (2012) Left Ventricular Hypertrophy and Geometry in Type 2 Diabetes Patients with Chronic Kidney Disease: An Echocardiographic Study. Cardiovascular Journal of Africa, 23, 73-77.
[12] Mansia, G., De Backer, G., Dominiczak, A., Cikova, R., Fagard, R., Germano, G., et al. (2007) Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press, 16, 135-232.
[13] World Health Organization (2000) The Problem of Overweight and Obesity: Preventing and Managing the Global Epidemic. Report Series 894, WHO, Geneva, 537.
[14] Dimitrieva, O., de Lusignan, S. and Goldsmith, D. (2013) Association of Anemia in Primary Care Patients with Chronic Kidney Disease: Cross-Sectional Study of Quality Improvement in Chronic Kidney Disease (AICKD) Trial Data. BMC Nephrology, 14, 24.
[15] Expert Committee on the Diagnosis and Classification of Diabetes (2003) Report of Expert Committee on the Diagnosis of and Classification of Diabetes Mellitus. Diabetes Care, 26, S5-S20.
[16] Levey, A.S., Greene, T. and Kusek, J.W. (2000) A Simplified Equation to Predict Glomerular Filtration Rate from Serum Creatinine. Journal of the American Society of Nephrology, 11, Article ID: A0828.
[17] K/DOQI, Kidney Disease Outcome Quality Initiative (2002) Clinical Practical guidelines for Chronic Kidney Disease (CKD). American Journal of Kidney Diseases, 39, S22-S26.
[18] National Heart Lung and Blood Institute (2001) Executive Summary of the Third of National Cholesterol Education Program (NCEP) Expert Panel on Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III) (2001). The Journal of the American Medical Association, 285, 2486-2497.
[19] Lang, R.M., Bierig, M., Devereux, R.B., Flachskamp, F.A., Foster, E., Pellikka, P.A., et al. (2006) American Society of Echocardiography’s Nomenclature and Standards Committee: Task Force on Chamber Quantification. American College of Cardiology Echocardiography Committee; American Heart Association; European Society of Echocardiography; European Society of Cardiology. Recommendations for Chamber Quantification. European Journal of Echocardiography, 17, 1460-1465.
[20] Adamu, U.G., Kolo, P.M., Katibi, I.A., Opadji, G.O., Omotsho, A.B. and Araoye, A.M. (2009) Relationship between Left Ventricular Diastolic Function and Geometric Patterns in Nigerians with Newly Diagnosed Systemic Hypertension. Cardiovascular Journal of Africa, 20, 173-177.
[21] Devereux, R.B., Alonso, D.R., Lucas, E.M., Gottlieb, E. and Reichek, I. (1986) Echocardiographic Assessment of Left Ventricular Hypertrophy: Comparison to Necropsy Findings. The American Journal of Cardiology, 57, 450-458.
[22] de Simone, G., Devereux, R.B., Daniels, S.R., Koren, M.J., Meyer, R.A. and Laragh, J.H. (1995) Effects of Growth on Variability of Left Ventricular Mass: Assessment of Allometric Signals in Adults and Children and Their Capacities to Predict Cardiovascular Risk. Journal of the American College of Cardiology, 25, 1056-1062.
[23] Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., et al. (2005) Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18, 1440-1463.
[24] Nardi, E., Palermo, A., Mulè, G., Cusimano, P., Cottone, S. and Cerasola, G. (2009) Left Ventricular Hypertrophy and Geometry in Hypertensive Patients with Chronic Kidney Disease. Journal of Hypertension, 27, 633-641.
[25] Redón, J., Cea-Calvo, L., Lozano, J.V., Fernández-Pérez, C., Navarro, J., Bonet, A. and González-Esteban, J., ERIC- HTA 2003 Study Investigators (2006) Kidney Function and Cardiovascular Disease in the Hypertensive Population: The ERIC-HTA Study. Journal of Hypertension, 24, 663-669.
[26] Ulasi, I.I., Arodiwe, E.B. and Ijoma, C.K. (2006) Left Ventricular Hypertrophy in African Black Patients with Chronic Renal Failure at First Evaluation. Ethnicity & Disease, 16, 859-864.
[27] Busari, O., Opadijo, G., Olarewaju, T., Omotoso, A. and Jimoh, A. (2010) Electrocardiographic Correlates of Microalbuminuria in Adult Nigerians with Essential Hypertension. Cardiology Journal, 17, 281-287.
[28] Adekunde, A.E., Adeseye, A.I., Adebayo, O.T., Olatayo, A.A., Joseph, O.O. and Ayodele, A.R. (2013) Left Ventricular Mass Formulae and Prevalence Rates of Echocardiographic Left Ventricular Hypertrophy in Nigerians with Essential Hypertension. North American Journal of Medical Sciences, 5, 325-329.
[29] Dada, A., Adebiyi, A.A., Aje, A., Oladapo, O.O. and Falase, A.O. (2005) Standard Electrocardiographic Criteria for Left Ventricular Hypertrophy in Nigerian Hypertensives. Ethnicity & Disease, 15, 578-584.
[30] Dada, A., Adebiyi, A.A., Aje, A., Oladapo, O.O. and Falase, A.O. (2006) Comparison of Araoye’s Criteria with Standard Electrocardiographic Criteria for Diagnosis of Left Ventricular Hypertrophy in Nigerian Hypertensives. West African Journal of Medicine, 25, 179-185.
[31] Niakara, A., Ouédraogo, N., Nébié, L.V., Samadoulougou, A.K., Kaboré, N.J. and Ouandaogo, B.J. (2001) Left Ventricular Hypertrophy in Hypertensive African Blacks: Echocardiographic Study of 452 Patients. Annales de Cardiologie et d’Angéiologie, 50, 197-201. (In French)
[32] Singh, A.K. and Kari, J.A. (2013) Metabolic Syndrome and Chronic Kidney Disease. Current Opinion in Nephrology and Hypertension, 22, 198-203.
[33] Chang, J.M., Chen, S.C., Huang, J.C., Su, H.M. and Chen, H.C. (2014) Anemia and Left Ventricular Hypertrophy with Renal Function Decline and Cardiovascular Events in Chronic Kidney Disease. The American Journal of the Medical Sciences, 347, 183-189.
[34] Fraser, S.D., Roderick, P.J., McIntyre, N.J., Harris, S., McIntyre, C.W., Fluck, R.J., et al. (2013) Suboptimal Blood Pressure Control in Chronic Kidney Disease Stage 3: Baseline Data from a Cohort Study in Primary Care. BMC Family Practice, 14, 88.
[35] Cerasola, G., Nardi, E., Palermo, A., Mule, G. and Cottone, S. (2011) Epidemiology and Pathophysiology of Left Ventricular Mass Abnormalities in Chronic Kidney Disease. Journal of Nephrology, 24, 1-10.
[36] Aje, A., Adebiyi, A.A., Oladapo, O.O., Dada, A., Ogah, O.S., Ojji, D.B. and Falae, A.O. (2006) Left Ventricular Geometric Patterns in Newly Presenting Nigerian Hypertensives: An Echocardiographic Study. BMC Cardiovascular Disorders, 6, 4.
[37] Adeseye, A., Olayinka, A. and Opadijo, G. (2010) Left Ventricular Hypertrophy, Geometric Patterns and Clinical Correlates among Treated Hypertensive Nigerians. Pan African Medical Journal, 4, 8.
[38] Kuch, B., von Scheidt, W., Peter, W., Heier, M., Wichmann, H.E. and Meisinger, C. (2006) Influence of Antihypertensive Therapy and Blood Pressure Control on Left Ventricular Geometry and Function in Subjects with Type 2 Diabetes: The Augsburg Diabetes Family Study. Journal of Human Hypertension, 20, 757-764.
[39] Gupta, J., Dominic, E.A., Fink, J.C., Ojo, A.O., Barrows, I.R., Reilly, M.P., et al. (2015) Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study. PLoS ONE, 10, e0124772.
[40] Sambi, R.S., Gaur, A.K., Hotchandani, R., Aggarwal, K.K., Kaur, S., Gupta, M., et al. (2011) Patterns of Left Ventricular Hypertrophy in Chronic Kidney Disease: An Echocardiographic Evaluation. Indian Heart Journal, 63, 259-268.
[41] Park, M., Hsu, C.Y., Li, Y., Mishra, R.K., Keane, M., Rosas, S.E., et al. and Chronic Renal Insufficiency Cohort (CRIC) Study Group (2012) Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD. Journal of the American Society of Nephrology, 23, 1725-1734.
[42] Mulè, G., Nardi, E., Guarino, L., Cacciatore, V., Geraci, G., Calcaterra, I., et al. (2015) Plasma Aldosterone and Its Relationship with Left Ventricular Mass in Hypertensive Patients with Early-Stage Chronic Kidney Disease. Hypertension Research, 38, 276-283.
[43] Arodiwe, E.B., Ulasi, I.L., Ijoma, C.K. and Ike, S.O. (2010) Left Ventricular Systolic Function in a Nigerian Pre-Dialysis Patient Population with Chronic Kidney Disease. Nigerian Postgraduate Medical Journal, 17, 301-307.
[44] Grabysa, R. and Wańkowicz, Z. (2013) Echocardiographic Markers of Left Ventricular Dysfunction among Men with Uncontrolled Hypertension and Stage 3 Chronic Kidney Disease. Medical Science Monitor, 19, 838-845.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.